DR. JONATHAN A MCCULLERS, MD
Medical Practice at Danny Thomas Pl, Memphis, TN

License number
Tennessee 28217
Category
Medical Practice
Type
Pediatric Infectious Diseases
Address
Address
262 Danny Thomas Pl, Memphis, TN 38105
Phone
(901) 595-3006
(901) 595-3842 (Fax)

Organization information

See more information about JONATHAN A MCCULLERS at bizstanding.com

Jonathan McCullers MD

332 N Lauderdale St, Memphis, TN 38105

Industry:
Pediatrician
Phone:
(901) 595-3006 (Phone)
Jonathan Arnold Mccullers

Professional information

Jonathan Mccullers Photo 1

Associate Member At St. Jude Children's Research Hospital

Location:
Greater Memphis Area
Industry:
Hospital & Health Care
Experience:
St. Jude Children's Research Hospital Nonprofit; 1001-5000 employees; Hospital & Health Care industry: Associate member,  (-) 


Jonathan Arnold Mccullers Photo 2

Jonathan Arnold McCullers, Memphis TN

Specialties:
Pediatrics, Pediatric Infectious Diseases, Infectious Disease
Work:
Saint Jude Children's Research Hospital
332 N Lauderdale St, Memphis, TN 38105 Saint Jude Children's Research Hospital
262 Danny Thomas Pl, Memphis, TN 38105 ULPS - General Pediatrics
50 N Dunlap St, Memphis, TN 38103
Education:
University of Alabama at Birmingham (1993)


Jonathan A Mccullers Photo 3

Dr. Jonathan A Mccullers, Memphis TN - MD (Doctor of Medicine)

Specialties:
Pediatric Infectious Disease Medicine
Address:
Le Bonheur Chldrns Hosp Pdtrcs
50 N Dunlap St, Memphis 38103
(901) 287-5437 (Phone)
Certifications:
Pediatric Infectious Disease Medicine, 2009, Pediatrics, 2005
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Alabama At Birmingham
Graduated: 1993
University Of Al Hospital


Jonathan A Mccullers Photo 4

Jonathan A McCullers, Memphis TN

Specialties:
Pediatrician
Address:
262 Danny Thomas Pl, Memphis, TN 38105
332 N Lauderdale St, Memphis, TN 38105
Board certifications:
American Board of Pediatrics Certification in Pediatrics, American Board of Pediatrics Sub-certificate in Pediatric Infectious Diseases (Pediatrics)


Jonathan Mccullers Photo 5

Use Of Neuraminidase Inhibitors To Prevent Flu Associated Bacterial Infections

US Patent:
2004024, Dec 9, 2004
Filed:
Mar 25, 2004
Appl. No.:
10/809127
Inventors:
Jonathan McCullers - Germantown TN, US
Assignee:
St. Jude Children's Research Hospital - Memphis TN
International Classification:
A61K031/7056, A61K031/551
US Classification:
514/043000, 514/220000
Abstract:
The invention provides a novel use for neuraminidase inhibitors in chemoprophylactic and treatment methods for the prevention, attenuation and treatment of bacterial infections that may occur in association with, or as a sequelae of, viral The prophylactic methods of the invention are particularly suitable for the prevention of secondary bacterial infections, such as, but not limited to infections of the lower respiratory tract (e.g., pneumonia), middle ear infections (e.g., otitis media) and bacterial sinusitis. The treatment methods are suitable for use in protocols designed to attenuate or treat bacterial infections that occur concurrent with, or as a sequelae of the flu.


Jonathan Mccullers Photo 6

Methods And Compositions For Preparing A Universal Influenza Vaccine

US Patent:
2010009, Apr 22, 2010
Filed:
Oct 17, 2007
Appl. No.:
12/445551
Inventors:
Jonathan A. McCullers - Memphis TN, US
Victor C. Huber - Dakota Dunes SD, US
Karen S. Slobod - Somerville MA, US
Julia L. Hurwitz - Germantown TN, US
Assignee:
St. Jude Children's Reseach Hospital - Memphis TN
International Classification:
A61K 39/295, A61K 39/00, A61K 39/145
US Classification:
4242021, 4241841, 4242091
Abstract:
Compositions and methods for preventing and treating influenza virus infections are provided. Compositions include novel immunogenic compositions having at least one vector capable of expressing an antigenic component from four or more influenza viruses representative of the antigenic diversity of a target population of influenza virus strains. Compositions further include novel immunogenic compositions having at least four vectors, each vector capable of expressing a single antigenic component representative of the antigenic diversity of a target population of influenza virus strains. In other aspects of the invention, the immunogenic compositions also include one or more viral proteins (or antigenic portions thereof), or one or more live attenuated viruses, derived from the target population of influenza virus strains. The invention further provides methods for making a multi-valent influenza vaccine and methods for inducing an immune response in a subject against influenza viruses.


Jonathan Mccullers Photo 7

Method And Kit For Detecting Virulent Strains Of Influenza Virus

US Patent:
2012028, Nov 8, 2012
Filed:
May 2, 2011
Appl. No.:
13/098770
Inventors:
Jonathan A. McCullers - Memphis TN, US
Julie McAuley - Thomastown, AU
Assignee:
St. Jude Children's Research Hospital - Memphis TN
International Classification:
C12Q 1/70, C07H 21/04, C07K 16/08
US Classification:
435 5, 536 2432, 536 2433, 5303879
Abstract:
The present invention is a kit and method for determining the virulence of an influenza virus based upon the presence or absence of leucine at position 62, arginine at position 75, arginine at position 79 and leucine at position 82 of the polymerase basic 1-F2 protein amino acid sequence.